Skip to content

Trial Summary

Tracking Residual Disease Using Circulating Tumour DNA In High-Risk Early Breast Cancer

Acronym:

TRAIL

ACTRN/NCT /ethics:

ACTRN12618001766202

Scientific title:

Tracking Residual Disease Using Circulating Tumour DNA In High-Risk Early Breast Cancer

Sponsor / Cooperative group:

National Breast Cancer Foundation

Trial & Patient Characteristics

Cancer TypeBreast
Trial TypeDiagnosis
Phase-
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer Stage-
Anticipated Start Date2018-10-31
Anticipated End Date2023-10-31

Participating Hospitals

HospitalLyell McEwin Hospital
Clinical Trial CoordinatorAndy Phay
Emailandy.phay@sa.gov.au
Phone08 8282 0833
Principal InvestigatorDr Louisa Lo
Recruitment StatusRecruiting